Filing search / Tempest Therapeutics, Inc. / "Tax" / Page 5

425

EX-10.3

6i7bxz9mzxg qbz

29 Mar 21

Business combination disclosure

7:27am

8-K

EX-10.1

99f8i9y2271hlny

28 Jan 21

Cost Associated with Exit or Disposal Activities

8:01am

8-K

EX-1.1

ig7wvoi xr3

4 Mar 20

Entry into a Material Definitive Agreement

8:37am

8-K

EX-1.1

f3ut4u224ml5a

5 Dec 19

Millendo Therapeutics Announces Proposed Public Offering of Common Stock

4:08pm

424B5

rzgs6hz0vlt5g 7f9

5 Dec 19

Prospectus supplement for primary offering

4:06pm

424B5

48ogq

4 Dec 19

Prospectus supplement for primary offering

4:12pm